Fasudil Trial for Treatment of Early Alzheimer's Disease (FEAD)

NCT06362707 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

200

Enrollment

OTHER_GOV

Sponsor class

Conditions

Cognitive Decline, Mild
Alzheimer Disease

Interventions

DRUG: Fasudil
DRUG: Placebo

Sponsor

Helse Stavanger HF

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]